NSRGY - Nestlé S.A.

Other OTC - Other OTC Delayed Price. Currency in USD
86.06
+0.35 (+0.41%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close85.71
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume427,575
Market Cap272.054B
Beta0.41
PE Ratio (TTM)28.56
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.28 (2.67%)
Ex-Dividend Date2017-04-07
1y Target EstN/A
Trade prices are not sourced from all markets
  • L'Oreal CEO Sees No Reason for Nestle to Change Stake
    Bloomberg Video6 days ago

    L'Oreal CEO Sees No Reason for Nestle to Change Stake

    Dec.07 -- Jean-Paul Agon, chief executive officer at L'Oreal, discusses the company's relationship with Nestle and overall outlook for L'Oreal. He speaks with Bloomberg's Francine Lacqua.

  • The company behind Kit Kat bars wants to start selling you health supplements
    Quartz6 days ago

    The company behind Kit Kat bars wants to start selling you health supplements

    In a substantial $2.3 billion deal, Nestlé, the maker of Kit Kat bars and DiGiorno’s frozen pizza, has acquired a company that makes organic and natural supplements. While buying Canadian-based Atrium Innovations might sound like a strange choice for the world’s largest food company, it actually fits into Nestlé’s long-term goals nicely. Executives at the…

  • The Wall Street Journal7 days ago

    [$$] Nestlé to Buy Atrium Innovations for $2.3 Billion

    Nestlé said it agreed to buy Atrium Innovations, a Canadian vitamin maker, for $2.3 billion from a consortium of investors led by private-equity firm Permira.

  • Reuters8 days ago

    Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

    Nestle (NESN.S) is buying Canadian vitamin maker Atrium Innovations for $2.3 billion (£1.7 billion), expanding its presence in consumer healthcare as it seeks to offset weakness in packaged foods. The world's largest packaged food company said on Tuesday it will buy the maker of vitamins, probiotics and meal replacements from a group of investors led by Permira Funds. Nestle Health Science already sells nutritional products for people with specific medical conditions and has been at the forefront of Nestle's ambition to become a "nutrition, health and wellness" company as packaged food sales slow, amid changing tastes.

  • Nestle to buy vitamin maker Atrium Innovations for $2.3 billion
    Reuters8 days ago

    Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

    Nestle is buying Canadian vitamin maker Atrium Innovations for $2.3 billion, expanding its presence in consumer healthcare as it seeks to offset weakness in packaged foods. The world's largest packaged food company said on Tuesday it will buy the maker of vitamins, probiotics and meal replacements from a group of investors led by Permira Funds. Nestle Health Science already sells nutritional products for people with specific medical conditions and has been at the forefront of Nestle's ambition to become a "nutrition, health and wellness" company as packaged food sales slow, amid changing tastes.

  • Nestle Investors Can Swallow This Herbal Growth Remedy
    Bloomberg8 days ago

    Nestle Investors Can Swallow This Herbal Growth Remedy

    Mark Schneider has the firepower to buy Atrium, with plenty to spare.

  • Associated Press8 days ago

    Nestle to buy health products maker Atrium for $2.3 billion

    GENEVA (AP) — Swiss consumer goods company Nestle says it is buying Atrium Innovations, a privately-held maker of nutritional health products, for $2.3 billion in cash.

  • Benzinga8 days ago

    Investors Love This Vanguard ETF

    Two obvious themes from the world of exchange traded funds this year are Vanguard's jaw-dropping growth and investors' preference for ex-U.S. developed markets funds. Those themes meet in the Vanguard ...

  • Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources
    Reuters12 days ago

    Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources

    LONDON/FRANKFURT (Reuters) - Swiss food giant Nestle (NESN.S) and the private equity owners of German drug firm Stada (STAGn.DE) are both preparing tentative bids for Merck KgaA's (MRCG.DE) consumer health unit, several sources told Reuters. Merck's financial adviser JPMorgan has invited bids for the business, which is valued at about 4 billion euros (£3.5 billion), ahead of a Dec. 15 deadline, the sources said. Nestle is widely seen as a natural buyer for the maker of Seven Seas vitamins and Bion nutritional supplements, after previous talks to set up a consumer joint venture with Merck fell through over the summer.

  • Reuters12 days ago

    Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources

    LONDON/FRANKFURT, Nov 30 (Reuters) - Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters. Merck's financial adviser JPMorgan has invited bids for the business, which is valued at about 4 billion euros ($4.8 billion), ahead of a Dec. 15 deadline, the sources said. Nestle is widely seen as a natural buyer for the maker of Seven Seas vitamins and Bion nutritional supplements, after previous talks to set up a consumer joint venture with Merck fell through over the summer.

  • Reuters14 days ago

    Indian court slaps Nestle India with fine over substandard noodles

    An Indian court on Tuesday imposed a fine of 4.5 million rupees ($70,000) on Nestle India (NEST.NS) in a 2015 case for selling substandard instant noodles after a laboratory test found high ash content in its popular Maggi brand. The court also slapped a 2.6 million rupee fine on the distributors of Nestle India, a unit of packaged food giant Nestle SA (NESN.S), said Ranjan Singh, a legal officer at the Shahjahanpur district court in the northern state of Uttar Pradesh on Wednesday. The case against the Swiss food firm's India unit is one of several filed by regulators after they found excess lead, ash, and monosodium glutamate (MSG), a flavour enhancer, in different samples of Maggi noodles seized in Uttar Pradesh between 2015 and 2016.

  • Reuters14 days ago

    Nestle, Cuba lay first stone for $55 million coffee and biscuit factory

    Cuba and Swiss firm Nestle on Tuesday laid the first stone of a $55 million coffee and biscuits factory joint venture in the Mariel special development zone, the latest major foreign investment in the Communist-run island. Nescor is Cuba's third joint venture with Nestle and reflects President Raul Castro's drive to attract international capital to help update the Soviet-style command economy and stimulate growth. Cuba created the zone around the Mariel port just west of Havana four years ago, offering companies significant tax and customs breaks.

  • Nestle, Cuba lay first stone for $55 million coffee and biscuit factory
    Reuters14 days ago

    Nestle, Cuba lay first stone for $55 million coffee and biscuit factory

    Cuba and Swiss firm Nestle (NESN.S) on Tuesday laid the first stone of a $55 million coffee and biscuits factory joint venture in the Mariel special development zone, the latest major foreign investment in the Communist-run island. Nescor is Cuba's third joint venture with Nestle and reflects President Raul Castro's drive to attract international capital to help update the Soviet-style command economy and stimulate growth. Cuba created the zone around the Mariel port just west of Havana four years ago, offering companies significant tax and customs breaks.

  • Morningstar21 days ago

    Do Foreign Small Caps Offer Better Diversification?

    Foreign small caps can be better diversifiers because they have closer ties to their local economies.

  • Benzinga22 days ago

    Wall Street's M&A Chatter From Nov. 20: Marvell Technology, Aetna, Bloomin' Brands, AT&T

    The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday, Nov. 20, 2017: Marvell Technology to Acquire Cavium for $6B  The Deal: Marvell Technology Group Ltd. (NASDAQ: ...

  • Nestle's Baby Food Diet
    Bloomberg22 days ago

    Nestle's Baby Food Diet

    Hain Celestial would be expensive, but the Swiss giant has reasons to pay up.

  • Nestle Unions Say More Than 1,000 French Jobs May Be at Risk
    Bloomberg22 days ago

    Nestle Unions Say More Than 1,000 French Jobs May Be at Risk

    Nestle SA’s job cuts in France will probably exceed 1,000 as the Swiss bottler of Perrier water prepares to shift support-staff roles out of the country, union officials said.

  • Asia's Consumers Snubbing Global Brands for These Products
    Bloomberg23 days ago

    Asia's Consumers Snubbing Global Brands for These Products

    Nestle SA is losing buzz to an Indonesian coffee brand famous for brewing civet-cat feces, and L’Oreal SA is losing face to a Chinese skincare brand favored by President Xi Jinping’s wife.

  • TheStreet.com23 days ago

    Candy-Selling Nestle May Want to Buy Organic Pioneer Hain?

    Insurgent investors are pressing both the Swiss packaged foods conglomerate and U.S. organic food target.

  • CNBC23 days ago

    Nestle reported to be among companies exploring a purchase of Hain Celestial

    The report comes after a fight with activist investor, Engaged Capital.

  • Nestle Is Among Potential Suitors for Hain Celestial
    Bloomberg23 days ago

    Nestle Is Among Potential Suitors for Hain Celestial

    Nestle SA is among companies exploring a purchase of Hain Celestial Group Inc., a U.S. maker of organic and vegetarian food, according to people familiar with the matter, as the Swiss giant seeks to expand ...

  • A Detailed Look Into Daniel Loeb’s Stock Portfolio
    InvestorPlace27 days ago

    A Detailed Look Into Daniel Loeb’s Stock Portfolio

    Daniel Loeb has made a name for himself generating impressive, and consistent, returns over the last two decades. In the process he has amassed a fortune of $3.2 billion, putting him at number 240 on the Forbes 400 list.

  • Reuters28 days ago

    Nestle shakes up infant nutrition to tackle local rivals

    LONDON/ZURICH (Reuters) - Nestle, the world's largest packaged food firm, is reorganising its infant nutrition unit to compete with regional rivals, the latest in a string of shake-ups for global packaged goods companies struggling to reignite sales. The change comes five months after Nestle's new CEO listed its highly profitable infant formula as a priority focus. Infant nutrition is a key battleground for Nestle and rivals such as Danone, which also ranks its baby unit as its most profitable, and Reckitt Benckiser, which recently bought Mead Johnson, the maker of infant formula Enfamil.

  • Reuters28 days ago

    Nestle shakes up infant nutrition to tackle local rivals

    LONDON/ZURICH (Reuters) - Nestle (NESN.S), the world's largest packaged food firm, is reorganising its infant nutrition unit to compete with regional rivals, the latest in a string of shake-ups for global packaged goods companies struggling to reignite sales. The change comes five months after Nestle's new CEO listed its highly profitable infant formula as a priority focus. Infant nutrition is a key battleground for Nestle and rivals such as Danone (DANO.PA), which also ranks its baby unit as its most profitable, and Reckitt Benckiser (RB.L), which recently bought Mead Johnson, the maker of infant formula Enfamil.

  • Reuters28 days ago

    Bayer hires new blood to stem 'Amazon effect' in consumer health

    German drugmaker Bayer (BAYGn.DE) has hired the head of Nestle's (NESN.S) baby food business to help it reverse a drop in revenue from consumer health brands, which often fail to appeal to buyers on Amazon (AMZN.O) and other online platforms. Bayer has appointed Nestle's Heiko Schipper, 48, to run the Consumer Health division as a group board member from March 1 next year, replacing Erica Mann, Bayer said in a statement on Wednesday. Bayer was caught off guard by the speed of U.S. consumers switching to online stores at the expense of established drugstores.